Open AccessMO244: PCSK9 Inhibitors are Efficient in Treatment of Resistant Hypercholesterolemia in Nephrotic Syndrome
Author(s) -
Ivana Vuković Lela,
Ema Ivandić,
Lana Gellineo,
Ana Jelaković,
Margareta Fištrek Prlić,
Bojan Jelaković
Publication year - 2022
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfac067.043
Subject(s) - medicine , nephrotic syndrome , evolocumab , interquartile range , proteinuria , gastroenterology , focal segmental glomerulosclerosis , statin , hyperlipidemia , renal function , urology , endocrinology , cholesterol , apolipoprotein b , diabetes mellitus , kidney , apolipoprotein a1
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom